• 142,240+ Medical Conferences
  • 273 Specialties
  • 10,719 Organizers
  • 153,627 Speakers
  • 156 Countries
  • 4,631 Cities
CME Conference Registrations Sold
Home  >  Speakers  >  Alexander Edward Perl
Alexander Edward Perl

Alexander Edward Perl

    MD, MS
Associate Professor | Philadelphia, Pennsylvania    United States of America
Oncology, Haematology
Hematology, Oncology,...More
Speaking at 2 events

Biography :

Dr. Alexander Perl is a member of the leukemia program in the Abramson Cancer Center and an Associate Professor in the Division of Hematology/Oncology at the Perelman School of Medicine at the University of Pennsylvania. His research focuses on molecularly-targeted therapeutics for acute leukemia. His principal expertise is in FLT3 inhibitors for AML and he has played a leading role in clinical trials of these agents. He also studies other agents targeting signal transduction, such as tyrosine kinase inhibitors for Ph-like ALL and inhibitors of oncogenic PI3K/AKT/mTOR signaling. His laboratory studies focus on phospho-specific flow cytometry of fixed, unfractionated blood and marrow as a method to quantify pharmacodynamic response to signal transduction inhibitors. He is additionally interested in preclinical drug screening in cellular and murine xenotransplantation models of acute leukemia.

For speaker's contact information - Contact us


Oncology, Haematology

Interested Topics

Hematology, Oncology, Internal Medicine, Blood cancer, Leukemia, Signal Transduction Inhibitors, Phospho-specific Flow Cytometry, Unfractionated Blood and Marrow, Myelodysplastic Syndromes

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Conference Session Materials

The conference session material has yet to be added by the speaker.

Appears with


Send Message